We are live on
!
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$375M
1-Year Est. Return
72.65%
This Fund
S&P 500
This Quarter
Est. Return
+0.57%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$209M
AUM Growth
+$2.2M
(+1.1%)
Cap. Flow
+$7.11M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
41.25%
Holding
111
New
24
Increased
26
Reduced
21
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$5.85M |
| 2 |
Alibaba
BABA
|
+$4.47M |
| 3 |
Uber
UBER
|
+$3.6M |
| 4 |
AstraZeneca
AZN
|
+$3.31M |
| 5 |
Cisco
CSCO
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$12M |
| 2 |
AbbVie
ABBV
|
+$4.03M |
| 3 |
argenx
ARGX
|
+$3.57M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.68M |
| 5 |
Turning Point Brands
TPB
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31% |
| 2 | Technology | 21% |
| 3 | Consumer Discretionary | 7.5% |
| 4 | Communication Services | 7.46% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NextNav
NN
$1.79B
| $158K | 0.08% |
+13,000
| New | +$157K |
|
77
Allot
ALLT
$372M
| $138K | 0.07% |
+24,238
| New | +$170K |
|
78
CALL
Teva Pharmaceuticals
TEVA
$40.8B
| $115K | 0.06% |
7,500
-7,500
| -50% | -$134K |
|
79
Altimmune
ALT
$552M
| $109K | 0.05% |
+21,770
| New | +$138K |
|
80
Wolfspeed
WOLF
$1.23B
| $84.2K | 0.04% |
27,500
+17,500
| +175% | +$102K |
|
81
PUT
Ionis Pharmaceuticals
IONS
$8.6B
| $45.3K | 0.02% |
+1,500
| New | +$49.1K |
|
82
CALL
LENSAR
LNSR
$61.5M
| $28.2K | 0.01% |
+2,000
| New | +$23K |
|
83
CALL
Corvus Pharmaceuticals
CRVS
$1.12B
| $15.9K | 0.01% |
+5,000
| New | +$23.6K |
|
84
Equillium
EQ
$139M
| $15.5K | 0.01% |
39,492
-23,455
| -37% | -$17.5K |
|
85
Boeing
BA
$171B
| – | – |
-7,000
| Closed | -$1.24M |
|
|
86
CALL
Cisco
CSCO
$457B
| – | – |
-12,500
| Closed | -$740K |
|
87
Deere & Co
DE
$160B
| – | – |
-2,000
| Closed | -$847K |
|
88
Ford
F
$58.5B
| – | – |
-100,000
| Closed | -$990K |
|
|
89
CALL
Ionis Pharmaceuticals
IONS
$8.6B
| – | – |
-2,000
| Closed | -$69.9K |
|
|
TBHC
90
DELISTED
The Brand House Collective
TBHC
| – | – |
-24,165
| Closed | -$39.1K |
|
91
Lineage Cell Therapeutics
LCTX
$269M
| – | – |
-107,751
| Closed | -$54.1K |
|
92
Nokia
NOK
$51B
| – | – |
-50,000
| Closed | -$222K |
|
93
Ovid Therapeutics
OVID
$414M
| – | – |
-11,750
| Closed | -$11K |
|
94
Sanofi
SNY
$103B
| – | – |
-14,500
| Closed | -$699K |
|
95
Flutter Entertainment
FLUT
$18.1B
| – | – |
-1,500
| Closed | -$388K |
|
Similar funds
JIC
CIM
AIM
MWM
RCP
HPM
CAG
LWMNY
DCF Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, DCF Advisers held 111 positions worth $209M, up 1.1% from $207M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
DCF Advisers deployed $7.11M of net new capital in Q1 2025, opening 24 new positions and adding to 26 existing holdings. Its largest new stake was Energy Transfer Partners: 300,500 shares worth $5.59M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Intra-Cellular Therapies Inc., an estimated $12M trimmed.
- DCF Advisers's largest Q1 2025 buy was Energy Transfer Partners: 300,500 shares worth $5.59M.
- DCF Advisers added most to Cisco in Q1 2025, an estimated $2.15M increase.
- DCF Advisers's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $12M.
- DCF Advisers fully exited Boeing in Q1 2025, selling an estimated $1.24M.
- DCF Advisers's ten largest holdings make up 41% of its $209M portfolio in Q1 2025.
- DCF Advisers opened 24 new positions and closed 25 in Q1 2025.
- DCF Advisers's portfolio value rose 1.1% quarter-over-quarter to $209M.
Based on DCF Advisers's 13F filing for Q1 2025, filed 9 May 2025.